As I posted earlier, I am very excited about this little gem. I think investors are beginning to understand the story:
1. Demonstrated management team leading a European and US market sales drive.
2. Patents out to 2031,with probable extensions to come.
3. A high barrier to entry - remember the work up to the PSO was about 14 years of development
4. A huge world market
5. Various Medicare related rebates in place
6. Game changing technology platform with further diagnostic tests in the pipeline.
Breaking into the medical field is never easy so a marketing strategy is paramount at this early phase of the company's life cycle. Will be important that quarterlies demonstrate increase sales volume.
As I posted earlier, I am very excited about this little gem. I...
Add GSS (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
67.5¢ |
Change
-0.015(2.17%) |
Mkt cap ! $155.4M | |||
| Open | High | Low | Value | Volume |
| 68.5¢ | 68.5¢ | 67.5¢ | $8.27K | 12.21K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 34322 | 67.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 68.5¢ | 7757 | 1 |
View Market Depth
| Last trade - 13.57pm 29/11/2024 (20 minute delay) ? |
| GSS (ASX) Chart |
